TY - JOUR
T1 - Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium
T2 - Part 1 - Kidney cancer
AU - Buti, Sebastiano
AU - Ciccarese, Chiara
AU - Iacovelli, Roberto
AU - Bersanelli, Melissa
AU - Scarpelli, Marina
AU - Lopez-Beltran, Antonio
AU - Cheng, Liang
AU - Montironi, Rodolfo
AU - Tortora, Giampaolo
AU - Massari, Francesco
PY - 2016/9/1
Y1 - 2016/9/1
N2 - The American Society of Clinical Oncology Genitourinary Cancers Symposium, Moscone West Building, San Francisco, CA, USA, 7-9 January 2016 The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, held in San Francisco (CA, USA), from 7 to 9 January 2016, focused on 'patient-centric care: translating research to results'. Every year, this meeting is a must for anyone studying genitourinary tumors to keep abreast of the most recent innovations in this field, exchange views on behaviors customarily adopted in daily clinical practice, and discuss future topics of scientific research. This two-part report highlights the key themes presented at the 2016 ASCO Genitourinary Cancers Symposium, with part 1 reporting the main novelties of kidney cancer and part 2 discussing the most relevant issues which have emerged for bladder and prostate tumors.
AB - The American Society of Clinical Oncology Genitourinary Cancers Symposium, Moscone West Building, San Francisco, CA, USA, 7-9 January 2016 The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, held in San Francisco (CA, USA), from 7 to 9 January 2016, focused on 'patient-centric care: translating research to results'. Every year, this meeting is a must for anyone studying genitourinary tumors to keep abreast of the most recent innovations in this field, exchange views on behaviors customarily adopted in daily clinical practice, and discuss future topics of scientific research. This two-part report highlights the key themes presented at the 2016 ASCO Genitourinary Cancers Symposium, with part 1 reporting the main novelties of kidney cancer and part 2 discussing the most relevant issues which have emerged for bladder and prostate tumors.
KW - biomarkers
KW - genitourinary cancer
KW - targeted therapy
UR - http://www.scopus.com/inward/record.url?scp=84983320411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84983320411&partnerID=8YFLogxK
U2 - 10.2217/fon-2016-0102
DO - 10.2217/fon-2016-0102
M3 - Article
AN - SCOPUS:84983320411
VL - 12
SP - 1967
EP - 1970
JO - Future Oncology
JF - Future Oncology
SN - 1479-6694
IS - 17
ER -